Cindy L. Schwartz

14.9k total citations · 4 hit papers
145 papers, 8.8k citations indexed

About

Cindy L. Schwartz is a scholar working on Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Cindy L. Schwartz has authored 145 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Pathology and Forensic Medicine, 52 papers in Pediatrics, Perinatology and Child Health and 51 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Cindy L. Schwartz's work include Lymphoma Diagnosis and Treatment (68 papers), Childhood Cancer Survivors' Quality of Life (51 papers) and Acute Lymphoblastic Leukemia research (47 papers). Cindy L. Schwartz is often cited by papers focused on Lymphoma Diagnosis and Treatment (68 papers), Childhood Cancer Survivors' Quality of Life (51 papers) and Acute Lymphoblastic Leukemia research (47 papers). Cindy L. Schwartz collaborates with scholars based in United States, Canada and Switzerland. Cindy L. Schwartz's co-authors include Debra L. Friedman, Wendy L. Hobbie, Neyssa Marina, Wendy M. Leisenring, Melissa M. Hudson, Nina S. Kadan‐Lottick, Kevin C. Oeffinger, Toana Kawashima, Anna T. Meadows and Charles A. Sklar and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Cindy L. Schwartz

142 papers receiving 8.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chronic Health Conditions in Adult Survivors of Childhood Cancer

2006 2.6k citations Kevin C. Oeffinger, Ann Mertens et al. New England Journal of Medicine profile →
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia

1999 884 citations Cindy L. Schwartz et al. New England Journal of Medicine profile →
American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects

2007 561 citations Cindy L. Schwartz et al. Journal of Clinical Oncology profile →
Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

2008 520 citations Paul A. Meyers, Cindy L. Schwartz et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cindy L. Schwartz United States	37	3.1k	2.3k	2.1k	2.1k	1.4k	145	8.8k
Stella M. Davies United States	64	3.4k 1.1×	3.6k 1.6×	4.3k 2.0×	1.3k 0.6×	435 0.3×	518	18.0k
Sy Ha China	53	1.0k 0.3×	2.6k 1.1×	1.1k 0.5×	2.8k 1.3×	3.1k 2.1×	341	14.3k
Smita Bhatia United States	43	3.2k 1.0×	2.2k 1.0×	2.7k 1.3×	1.0k 0.5×	1.1k 0.8×	359	8.4k
Jean E. Sanders United States	66	2.0k 0.7×	3.7k 1.6×	3.5k 1.6×	1.3k 0.6×	202 0.1×	191	15.4k
Nita L. Seibel United States	52	3.0k 1.0×	2.3k 1.0×	2.9k 1.3×	1.5k 0.7×	148 0.1×	153	9.8k
Charles B. Pratt United States	50	1.0k 0.3×	2.8k 1.2×	1.2k 0.6×	3.7k 1.8×	684 0.5×	198	8.5k
Jakob Passweg Switzerland	72	1.6k 0.5×	6.1k 2.7×	2.7k 1.3×	1.2k 0.6×	241 0.2×	497	21.0k
Daniel E. Fürst United States	64	821 0.3×	1.4k 0.6×	1.1k 0.5×	1.8k 0.9×	508 0.4×	258	22.1k
George R. Buchanan United States	57	2.3k 0.7×	1.0k 0.5×	1.3k 0.6×	1.0k 0.5×	268 0.2×	313	12.6k
John S. Najarian United States	76	1.4k 0.4×	2.0k 0.9×	4.2k 2.0×	2.8k 1.4×	352 0.2×	612	21.7k

Countries citing papers authored by Cindy L. Schwartz

Since Specialization

Citations

This map shows the geographic impact of Cindy L. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cindy L. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cindy L. Schwartz more than expected).

Fields of papers citing papers by Cindy L. Schwartz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cindy L. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cindy L. Schwartz. The network helps show where Cindy L. Schwartz may publish in the future.

Co-authorship network of co-authors of Cindy L. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Cindy L. Schwartz. A scholar is included among the top collaborators of Cindy L. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cindy L. Schwartz. Cindy L. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marks, Lianna J., Yue Wu, Kathleen M. McCarten, et al.. (2025). PET Response and Outcome in Low‐Risk Nodular Lymphocyte‐Predominant Hodgkin Lymphoma: Children's Oncology Group Study AHOD03P1. Pediatric Blood & Cancer. 72(5). e31606–e31606. 1 indexed citations

Chen, Yan, Yutaka Yasui, Rachel Phelan, et al.. (2024). Long‐term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS). Pediatric Blood & Cancer. 71(10). e31189–e31189. 2 indexed citations

Chow, Eric J., Sanjeev Aggarwal, David R. Doody, et al.. (2023). Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer. Journal of Clinical Oncology. 41(12). 2248–2257. 40 indexed citations

Koyama, Tatsuki, Lili Sun, Suzanne L. Wolden, et al.. (2022). Post-Traumatic Stress Symptoms in Adolescent Hodgkin Lymphoma Survivors: A Report from Children's Oncology Group AHOD0031. Journal of Adolescent and Young Adult Oncology. 12(3). 359–365. 3 indexed citations

Chow, Eric J., Richard Aplenc, Lynda M. Vrooman, et al.. (2021). Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group. Cancer. 128(4). 788–796. 38 indexed citations

Lo, Andrea, Amy Liu, Qi Liu, et al.. (2021). The Evolution of Children's Oncology Group Hodgkin Lymphoma Trials: Predicted Impact on Late Cardiac Toxicity. Blood. 138(Supplement 1). 881–881. 2 indexed citations

Welch, Jennifer, Lisa B. Kenney, G. Naheed Usmani, et al.. (2017). Understanding predictors of continued long‐term pediatric cancer care across the region: A report from the Consortium for New England Childhood Cancer Survivors. Pediatric Blood & Cancer. 64(10). 12 indexed citations

Kahn, Justine M., Kara M. Kelly, Qinglin Pei, et al.. (2017). Survival By Race/Ethnicity in Children and Adolescents with Hodgkin Lymphoma Treated on Cooperative Group Trials in the U.S. and Canada: A Pooled Analysis of Children's Oncology Group Trials. Blood. 130. 607–607. 2 indexed citations

Macpherson, Catherine Fiona, Mary C. Hooke, Debra L. Friedman, et al.. (2015). Exercise and Fatigue in Adolescent and Young Adult Survivors of Hodgkin Lymphoma: A Report from the Children's Oncology Group. Journal of Adolescent and Young Adult Oncology. 4(3). 137–140. 7 indexed citations

10.

Barkauskas, Donald A., Mark Krailo, Sajida Piperdi, et al.. (2014). HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study. Pediatric Blood & Cancer. 61(9). 1558–1564. 17 indexed citations

11.

Voss, Stephan D., Lu Chen, Louis S. Constine, et al.. (2012). Surveillance Computed Tomography Imaging and Detection of Relapse in Intermediate- and Advanced-Stage Pediatric Hodgkin's Lymphoma: A Report From the Children's Oncology Group. Journal of Clinical Oncology. 30(21). 2635–2640. 44 indexed citations

12.

Kelly, Michael, et al.. (2009). Bacteremia in febrile nonneutropenic pediatric oncology patients. Pediatric Blood & Cancer. 54(1). 83–87. 27 indexed citations

13.

Meyers, Paul A., Cindy L. Schwartz, Mark Krailo, et al.. (2008). Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group. Journal of Clinical Oncology. 26(4). 633–638. 520 indexed citations breakdown →

14.

Mahone, E. Mark, et al.. (2007). Motor and Perceptual Timing Deficits Among Survivors of Childhood Leukemia. Journal of Pediatric Psychology. 32(8). 918–925. 15 indexed citations

15.

Oeffinger, Kevin C., Ann Mertens, Charles A. Sklar, et al.. (2006). Chronic Health Conditions in Adult Survivors of Childhood Cancer. New England Journal of Medicine. 355(15). 1572–1582. 2551 indexed citations breakdown →

16.

Schwartz, Cindy L.. (2005). Survivors of childhood and adolescent cancer : a multidisciplinary approach. DIAL (Catholic University of Leuven). 26 indexed citations

17.

Schwartz, Cindy L.. (2005). Special issues in pediatric Hodgkin's disease. European Journal Of Haematology. 75(s66). 55–62. 25 indexed citations

18.

Schwartz, Cindy L.. (2004). Health status of adult long-term survivors of childhood cancer:a report from the Childhood Cancer Survivor Study.. PubMed. 144(3). 407–8. 3 indexed citations

19.

Schwartz, Cindy L.. (1995). Late effects of treatment in long-term survivors of cancer. Cancer Treatment Reviews. 21(4). 355–366. 31 indexed citations

20.

Schwartz, Cindy L., Neil R. Miller, Moody D. Wharam, & Brigid G. Leventhal. (1989). The optic nerve as the site of initial relapse in childhood acute lymphoblastic leukemia. Cancer. 63(8). 1616–1620. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact